Chemokines are signals in the body that act as beacons, calling out to migrating cells, such as white blood cells, guiding them to where they are needed. One chemokine in particular, chemokine 25 (CCL25), binds to chemokine Receptor 9 (CCR9), forming a signaling pathway that is important in the small intestine and colon, where it regulates immune response and decreases cell death.
Drs. Steven Lipkin, Xiling Shen, and colleagues at Cornell University have discovered that the CCL25-CCR9 pathway also has an unexpected role— inhibiting colon cancer metastasis and invasion.